INS and type 2 diabetes mellitus: The apparent improvement of beta cells function by short-term intensive insulin treatment in early T2D patients [180] may delay, but not prevent, the progressive beta cells failure driven by chronic insulin treatment and hyperactive mTORC1 [131].